Literature DB >> 11193036

Role of apoptosis in the response of lung carcinomas to anti-cancer treatment.

B Joseph1, R Lewensohn, B Zhivotovsky.   

Abstract

Resistance of tumor cells to treatment often accounts for the failure of traditional forms of anti-cancer therapy. It is well known that tumors from the same histological group and stage of development are highly heterogeneous in their sensitivity to therapy. Among the factors that can influence tumor sensitivity are DNA repair capacity, distribution of cells throughout the cell cycle, proliferation potential, etc. In many cases, anti-cancer therapy eliminates tumor cells via apoptosis, an active form of cell death characterized by cell shrinkage and the removal of cells in a neat, orderly fashion. However, this process is not always efficient. In the present review, the precise role that apoptosis plays in the response of lung carcinomas to chemotherapy and radiation treatment is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193036     DOI: 10.1111/j.1749-6632.2000.tb05613.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  The value of serum Bcl-2 levels in advanced lung cancer patients.

Authors:  Faruk Tas; Derya Duranyildiz; Hilal Oguz; Hakan Camlica; Ethem Nezih Oral; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

2.  Phagocytic clearance of apoptotic cells: role in lung disease.

Authors:  Jeong H Yun; Peter M Henson; Rubin M Tuder
Journal:  Expert Rev Respir Med       Date:  2008-12       Impact factor: 3.772

3.  SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.

Authors:  Jacqueline C Shultz; Rachel W Goehe; Charuta S Murudkar; Dayanjan S Wijesinghe; Eric K Mayton; Autumn Massiello; Amy J Hawkins; Prabhat Mukerjee; Ryan L Pinkerman; Margaret A Park; Charles E Chalfant
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

4.  Evaluation of chemotherapy response in VX2 rabbit lung cancer with 18F-labeled C2A domain of synaptotagmin I.

Authors:  Feng Wang; Wei Fang; Ming-Rong Zhang; Ming Zhao; Biao Liu; Zizheng Wang; Zichun Hua; Min Yang; Katsushi Kumata; Akiko Hatori; Tomoteru Yamasaki; Kazuhiko Yanamoto; Kazutoshi Suzuki
Journal:  J Nucl Med       Date:  2011-03-18       Impact factor: 10.057

5.  Preclinical imaging of therapy response using metabolic and apoptosis molecular imaging.

Authors:  Marijke De Saint-Hubert; Huijun Wang; Ellen Devos; Kathleen Vunckx; Lin Zhou; Chris Reutelingsperger; Alfons Verbruggen; Luc Mortelmans; Yicheng Ni; Felix M Mottaghy
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

6.  [Apoptosis and tumor regression in locally advanced non-small cell lung cancer with neoadjuvant therapy].

Authors:  K Junker; K-M Müller; U Bosse; F Klinke; A Heinecke; M Thomas
Journal:  Pathologe       Date:  2003-03-13       Impact factor: 1.011

Review 7.  Apoptosis block as a barrier to effective therapy in non small cell lung cancer.

Authors:  Ian Paul; J Mark Jones
Journal:  World J Clin Oncol       Date:  2014-10-10

Review 8.  Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention.

Authors:  Martin R Jadus; Josephine Natividad; Anthony Mai; Yi Ouyang; Nils Lambrecht; Sandor Szabo; Lisheng Ge; Neil Hoa; Maria G Dacosta-Iyer
Journal:  Clin Dev Immunol       Date:  2012-07-29

Review 9.  The role of mitochondria in the development and progression of lung cancer.

Authors:  Emily R Roberts; Kelly Jean Thomas
Journal:  Comput Struct Biotechnol J       Date:  2013-12-07       Impact factor: 7.271

10.  A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy.

Authors:  Dagmar S Lang; Daniel Droemann; Holger Schultz; Detlev Branscheid; Christian Martin; Anne R Ressmeyer; Peter Zabel; Ekkehard Vollmer; Torsten Goldmann
Journal:  Respir Res       Date:  2007-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.